Seegnal Reports Second Quarter 2026 Financial Results and Provides Business Update
Expanded Israeli Hospital Footprint with Five-Year Deployment at Nazareth Hospital EMMS Second Quarter Revenue Increased 15% to $351,000 and First Half Revenue Increased 16% to $706,000 CALGARY, Alberta, Sept. 01, 2026 (GLOBE NEWSWIRE) — Seegnal Inc. (TSXV: SEGN) (“Seegnal” or the “Company”), a developer of innovative healthcare technology focused on mitigating medication risks, today reported […]
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
